In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Principal Financial Group Inc (NYSE:PFG), Dunkin' Brands Group, Inc. (NASDAQ:DNKN), Dell Technologies Inc. (NYSE:DVMT), Paramount Group, Inc. (NYSE:PGRE), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PFG DOWNLOAD: http://Fundamental-Markets.com/register/?so=PFG DNKN DOWNLOAD: http://Fundamental-Markets.com/register/?so=DNKN DVMT DOWNLOAD: http://Fundamental-Markets.com/register/?so=DVMT PGRE DOWNLOAD: http://Fundamental-Markets.com/register/?so=PGRE SRNE DOWNLOAD: http://Fundamental-Markets.com/register/?so=SRNE LXRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=LXRX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Principal Financial Group Inc (NYSE:PFG), Dunkin' Brands Group, Inc. (NASDAQ:DNKN), Dell Technologies Inc. (NYSE:DVMT), Paramount Group, Inc. (NYSE:PGRE), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 16th, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

PRINCIPAL FINANCIAL GROUP INC (PFG) REPORT OVERVIEW

Principal Financial Group's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Principal Financial Group reported revenue of $4,627.80 vs $2,818.00 (up 64.22%) and diluted earnings per share $2.76 vs $1.06 (up 160.38%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Principal Financial Group reported revenue of $12,394.10 vs $11,964.40 (up 3.59%) and diluted earnings per share $4.50 vs $4.06 (up 10.84%). Principal Financial Group is expected to report earnings on January 29th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.27. The estimated EPS forecast for the next fiscal year is $5.61 and is expected to report on January 29th, 2018.

To read the full Principal Financial Group Inc (PFG) report, download it here: http://Fundamental-Markets.com/register/?so=PFG

-----------------------------------------

DUNKIN' BRANDS GROUP, INC. (DNKN) REPORT OVERVIEW

Dunkin' Brands Group's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Dunkin' Brands Group reported revenue of $224.17 vs $207.10 (up 8.24%) and diluted earnings per share $0.57 vs $0.57 (unchanged). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Dunkin' Brands Group reported revenue of $828.89 vs $810.93 (up 2.21%) and diluted earnings per share $2.11 vs $1.08 (up 95.37%). Dunkin' Brands Group is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.64. The estimated EPS forecast for the next fiscal year is $2.63 and is expected to report on February 8th, 2018.

To read the full Dunkin' Brands Group, Inc. (DNKN) report, download it here: http://Fundamental-Markets.com/register/?so=DNKN

-----------------------------------------

DELL TECHNOLOGIES INC. (DVMT) REPORT OVERVIEW

Dell Technologies' Recent Financial Performance

For the three months ended July 31st, 2017 vs July 31st, 2016, Dell Technologies reported revenue of $19,299.00 vs $13,080.00 (up 47.55%) and diluted earnings per share -$1.23 vs $1.41. For the twelve months ended January 31st, 2017 vs January 31st, 2016, Dell Technologies reported revenue of $61,642.00 vs $50,911.00 (up 21.08%) and diluted earnings per share -$2.79 vs -$2.72. Dell Technologies is expected to report earnings on December 14th, 2017. The report will be for the fiscal period ending October 31st, 2017.

To read the full Dell Technologies Inc. (DVMT) report, download it here: http://Fundamental-Markets.com/register/?so=DVMT

-----------------------------------------

PARAMOUNT GROUP, INC. (PGRE) REPORT OVERVIEW

Paramount Group's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Paramount Group reported revenue of $179.77 vs $171.32 (up 4.93%) and diluted earnings per share -$0.04 vs $0.00. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Paramount Group reported revenue of $683.34 vs $662.41 (up 3.16%) and diluted earnings per share -$0.05 vs -$0.02. Paramount Group is expected to report earnings on February 28th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $0.97 and is expected to report on February 28th, 2018.

To read the full Paramount Group, Inc. (PGRE) report, download it here: http://Fundamental-Markets.com/register/?so=PGRE

-----------------------------------------

SORRENTO THERAPEUTICS, INC. (SRNE) REPORT OVERVIEW

Sorrento Therapeutics' Recent Financial Performance

For the three months ended June 30th, 2017 vs June 30th, 2016, Sorrento Therapeutics reported revenue of $4.67 vs $0.90 (up 417.18%) and diluted earnings per share -$0.20 vs -$0.93. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Sorrento Therapeutics reported revenue of $8.15 vs $4.59 (up 77.6%) and diluted earnings per share -$1.21 vs -$1.24. Sorrento Therapeutics is expected to report earnings on November 8th, 2017. The report will be for the fiscal period ending September 30th, 2017. The estimated EPS forecast for the next fiscal year is -$0.65 and is expected to report on March 20th, 2018.

To read the full Sorrento Therapeutics, Inc. (SRNE) report, download it here: http://Fundamental-Markets.com/register/?so=SRNE

-----------------------------------------

LEXICON PHARMACEUTICALS, INC. (LXRX) REPORT OVERVIEW

Lexicon Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Lexicon Pharmaceuticals reported revenue of $26.94 vs $27.72 (down 2.8%) and diluted earnings per share -$0.29 vs -$0.35. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Lexicon Pharmaceuticals reported revenue of $83.34 vs $130.01 (down 35.9%) and diluted earnings per share -$1.36 vs -$0.05. Lexicon Pharmaceuticals is expected to report earnings on March 2nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$0.95 and is expected to report on March 2nd, 2018.

To read the full Lexicon Pharmaceuticals, Inc. (LXRX) report, download it here: http://Fundamental-Markets.com/register/?so=LXRX

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: andrew.duffie@fundamental-markets.com

2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Principal Financial (NASDAQ:PFG)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Principal Financial Charts.
Principal Financial (NASDAQ:PFG)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Principal Financial Charts.